SCHEMBL17625261

SCHEMBL17625261

CC1(c2ccc(Oc3cc(Oc4ccc(C5(C)N=N5)cc4)cc(Oc4ccc(C5(C(F)(F)F)N=N5)cc4)c3)cc2)N=N1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.35
GABRA1 P14867 3/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
DUSP3 P51452 1/20 0.31
GABRB2 P47870 2/20 0.31
ADRA2A P08913 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
NLRP3 Q96P20 1/20 0.30
MITF O75030 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
GFER P55789 1/20 0.30
NLRP1 Q9C000 1/20 0.30
NOD2 Q9HC29 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20348937 1.00 KIF11 (0.35) KIF11GABRA1GABRG2GABRB3ALDH1A1
SCHEMBL17629727 0.90 KIF11 (0.41) KIF11GABRA1GABRG2GABRB3ALDH1A1
SCHEMBL20348933 0.88 RAB9A (0.34) KIF11GABRA1GABRG2GABRB3RAB9A
SCHEMBL20348934 0.82 ALDH1A1 (0.34) ALDH1A1
SCHEMBL20336331 0.80 KIF11 (0.39) KIF11GABRA1GABRG2GABRB3SMN1; SMN2
SCHEMBL20348928 0.80 KIF11 (0.51) KIF11GABRA1GABRG2GABRB3GABRB2
SCHEMBL20348936 0.79 HTT (0.40) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL20348923 0.78 MAOB (0.43)
SCHEMBL20336334 0.78 KIF11 (0.37) KIF11GABRA1GABRG2GABRB3DUSP3
SCHEMBL17625265 0.75 GABRA1 (0.36) KIF11GABRA1GABRG2GABRB3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938241-B2 Diazirine compounds and compositions derived therefrom PROMERUS, LLC (US) 2018-04-10 US disclosed
US-20160083352-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM SUMITOMO BAKELITE CO., LTD. (JP) 2016-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083352-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM RDX, AOX1, ALDH1A2 KIF11 2915/4885GABRA1 1904/4885GABRG2 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.